Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

Treatment Trials Program

Funder: The Stanley Medical Research Institute (SMRI)

Geographic Scope: International (applications accepted worldwide)

Focus Areas:

  • Target Conditions: Schizophrenia, Bipolar Disorder, and related psychiatric conditions

  • Research Type: Clinical treatment trials testing novel pharmacological and non-pharmacological interventions

  • Study Design: SMRI gives strong preference to randomized, double-blind studies
    • Eligibility

    • Principal Investigator must have appropriate credentials and institutional affiliation
    • Co-investigators allowed (up to 5 listed in application)
    • Studies must have IRB (Ethical) approval before funding is released (approval status of "pending" acceptable at application submission)
    • International applications welcome

      What SMRI Supports

    • Personnel/Salary costs for study staff
    • Patient recruitment and retention costs
    • Supplies and equipment necessary for the trial
    • Indirect costs up to 15% of total project costs
    • Consultant assistance (no cost to applicant) for:
    • - Optimal trial design - Inclusion and exclusion criteria development - Clinical report form (CRF) development - Data management - Statistical analysis - Dropout data evaluation - Available consultants: Dr. John Davis (University of Illinois at Chicago, SMRI Associate Director) and Dr. Mark Weiser (Chaim Sheba Medical Center, Tel Aviv)

      Funding Distribution

    • 25% released in advance upon approval
    • 65% paid quarterly based on number of patients randomized
    • 10% released upon receipt of final report

    Requirements and Policies

    Data and Safety Monitoring Board (DSMB):

  • Required for all newly funded studies involving more than minimal risk (since 2009)

  • Minimum 3 members, at least one from outside the institution

  • At least one member should have biostatistics/clinical trial design expertise

  • At least one member should have English proficiency (verbal and written)

  • Meetings required at least every 6 months (teleconference acceptable)

  • Written reports required at least annually and at study end

  • All reports submitted to SMRI with fourth quarter report
  • Data Sharing Requirements:

  • SMRI expects timely release of final research data (raw, individual patient data)

  • Limited access datasets made available no later than 6 months after publication of main findings

  • Data must be de-identified to protect participant privacy

  • All researchers accessing SMRI data must execute Data Use Certification (DUC)

  • SMRI follows NIH data sharing guidelines

  • Applicants must explain any data sharing limitations in application
  • Special Trial Programs:

  • Special Treatment Trials: Multi-center trials requiring >$300,000/year, usually for medications with promising preliminary SMRI-supported trial results

  • Drug Development: Occasional support for promising medications at selected biotechnology companies (note: new applications not being accepted at this time)
    • Design Considerations

    • Applicants may consider Sequential Parallel Comparison Design (SPCD) for placebo-controlled trials
    • Interim analysis recommended for large trials
    • SMRI may request protocol modification to combine data across trials on same drug
    • Trimentum™ technology available through PPD for trial design and analysis

    Contact Information: Available through stanleyresearch.org

    How to Apply

    Application Process

    The treatment trial application consists of 7 parts submitted online:

    #### Part 1: Investigators
    1. List Principal Investigator (PI) with:
    - Salutation, first name, middle name, last name
    - Job title
    - Department
    - Institution name and address
    - Phone, fax, email
    - Degrees
    2. List all co-investigators (up to 5 additional co-investigators) with same information
    3. Required attachments: CVs for PI and all co-PIs (not to exceed 5 pages each)

    #### Part 2: Treatment Trial Details
    1. Fill in the following required fields:
    - Title of Proposed Treatment Trial
    - Primary Drug and Dose (required)
    - Secondary Drug and Dose (if any)
    - Target Population (required): Select from Schizophrenia or Bipolar Disorder
    - Total Sample Size (required)
    - Study Period for Each Subject (in days, required)
    - Length of Entire Trial (in years, required): Choose One Year, Two Years, or Three Years
    - Study Design (e.g., double blind, crossover, etc.)

    #### Part 3: Abstract and Proposal
    1. Abstract (500 words or less, including spaces):
    - Copy and paste abstract into text field
    - Optional: Attach charts/graphs via Media Upload

    2. Proposal Summary (approximately 5 pages, required):
    - Include the following elements:
    a) Scientific rationale for the study, citing relevant basic research and prior clinical experience with the drug
    b) Detailed study design including outcome measurements
    c) Description of how compounds will be obtained
    - Copy and paste summary into text field
    - Figures and tables should be limited to 1-2 figures per application
    - Optional: Attach charts/graphs via Media Upload

    #### Part 4: Blood Brain Barrier
    1. Answer: "Does this compound cross the blood brain barrier?" (Yes/No)
    2. Provide explanation (no character limit):
    - If YES: Brief explanation of supporting data that it crosses the blood brain barrier
    - If NO: Explain why the compound will be helpful for treating schizophrenia or bipolar disorder

    #### Part 5: References and Attachments
    1. List of references (not to exceed 5 pages):
    - Upload as attachment
    2. CVs attachment section:
    - PI CV (not to exceed 5 pages)
    - Co-PI CVs (not to exceed 5 pages each)
    3. Figures/charts attachment section:
    - Limited to 1-2 figures per application

    #### Part 6: Budget Items
    1. Provide line-by-line budget items:
    - All figures in U.S. dollars
    - Specify for each item:
    - Category: Personnel/Salary, Patient Costs, Supplies, Equipment, or Other
    - Item Name
    - Item Amount
    2. Personnel/Salary costs: List individually for each person
    3. Other items: May be grouped by category
    4. Indirect costs: May include up to 15% of total costs
    5. Total Amount Requested
    6. Note: If additional detail needed, review panel will request it
    7. Consultant Assistance: If requesting SMRI consultant help (for trial design, CRF development, data management, statistical analysis, etc.), do NOT include cost—SMRI will add estimated cost

    #### Part 7: Funding Sources and IRB Approval Status
    1. List all funding sources (pending and secured):
    - Related to proposed research
    - Other than proposed SMRI funding
    - Clearly note if funding is "pending" or "secured"

    2. IRB (Ethical) Approval Status (check appropriate box):
    - Received (already have approval)
    - Pending (approval in process)
    - Will apply when grant application is approved for funding
    - Note: IRB approval NOT required before submission, but must be provided before funding is released

    #### Final Steps
    1. Review entire application
    2. Option to print application
    3. Click "Submit Application" to enter into review system
    4. Important: Only applications marked as "submitted" from your account will be reviewed

    Application Assistance

    SMRI offers no-cost consultant support for approved applicants in the following areas:

  • Optimal trial design

  • Inclusion and exclusion criteria for patient selection

  • Clinical report form (CRF) development

  • Data management (including possibility of SMRI central data entry)

  • Dropout data evaluation

  • Statistical analysis
  • Indicate on application if consultant assistance desired upon funding approval.

    Focus Areas & Funding Uses

    Fields of Work

    science-researchmental-health

    Categories

    Browse similar grants by category

    Related Grants

    Similar grants from this funder and related organizations

    Ready to apply for Treatment Trials Program?

    Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.